Chapter 20. New Chemotherapeutic Agents in Lung Cancer

  1. Jack A. Roth MD, F.A.C.S.1,
  2. James D. Cox MD2 and
  3. Waun Ki Hong MD, D.M.Sc. (Hon.)3
  1. Anne S. Tsao

Published Online: 16 APR 2008

DOI: 10.1002/9780470696330.ch20

Lung Cancer, Third Edition

Lung Cancer, Third Edition

How to Cite

Tsao, A. S. (2008) New Chemotherapeutic Agents in Lung Cancer, in Lung Cancer, Third Edition (eds J. A. Roth, J. D. Cox and W. K. Hong), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470696330.ch20

Editor Information

  1. 1

    Professor and Bud Johnson Clinical Distinguished Chair, Department of Thoracic and Cardiovascular Surgery, Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Innovative Cancer Therapies, Chief, Section of Thoracic Molecular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

  2. 2

    Professor and Head, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

  3. 3

    American Cancer Society Professor, Samsung Distinguished University Chair in Cancer Medicine, Professor and Head, Division of Cancer Medicine Professor, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2008

ISBN Information

Print ISBN: 9781405151122

Online ISBN: 9780470696330

SEARCH

Keywords:

  • lung cancer;
  • chemotherapeutic agents;
  • taxanes;
  • paclitaxel;
  • tumor

Summary

This chapter contains section titled:

  • Introduction

  • Taxanes

  • Antimetabolites

  • Topoisomerase Inhibitors

  • Vinka Alkaloids

  • Multitargeted Antifolate

  • Treatment of NSCLC—moving Beyond Cytotoxics

  • Targeted Therapies

  • References